Skip to content
  1. Home/
  2. Johnson & Johnson Files Motion Seeking Dismissal of Federal MDL Talc Ovarian Cancer Claims

Johnson & Johnson Files Motion Seeking Dismissal of Federal MDL Talc Ovarian Cancer Claims

June 11, 2026 - Attributable to Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson:   

“Plaintiffs’ withdrawal of their only specific causation experts leaves them unable to satisfy an essential element of their claims, which mandates the dismissal of the claims, with prejudice. More broadly, the experts’ concessions elicited during the hearing regarding their opinions affirm that, as decades of science establishes, no plaintiff can make the requisite showing that talc caused their harm, and that this litigation should be put to rest.”